British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump’s possible tariffs on the sector. Post navigation Will Cardinals Choose Another Outsider Like Francis To Be Next Pope?Milwaukee Police’s ‘Shady’ Deal: Trading Millions Of Mugshots For Facial Recognition Tech